Retractable Technologies, Inc. (RVP) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Retractable Technologies (RVP) is a family-owned business with an impeccable credit history and a conservative management approach, although investors are anticipating more aggressive acquisition deals. The company relies on its ownership of key patents in the safe syringe segment, which guarantee consistent orders. Serving as the primary valuation tool, this price chart records the indicator at 0.00. Meanwhile, yield growth is constrained by severe market pressure and fixed material costs.
Comprehensive metric breakdowns and analytics for retractable.com (RVP)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- company total debt and liquidity indicators:
Debt to Equity Retractable Technologies|RVP - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Retractable Technologies, Inc.|RVP - Company Aggregate Debts|Debt to Book Capitalization Ratio Retractable Technologies, Inc.|RVP - Company Long-Term Liabilities|Company Short-Term Debts Retractable Technologies|Quick Liquidity retractable.com
- business earnings and investment ratios data:
RVP - Company Profit|Future Profit Retractable Technologies|RVP - Market Price to Net Income Ratio|Future Price to Earnings Retractable Technologies, Inc.|RVP - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Retractable Technologies, Inc.|RVP - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Retractable Technologies|RVP - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months retractable.com|RVP - Net earnings per one share growth for the current year|Net earnings per share growth forecast for next year Retractable Technologies
Fundamental company analysis:RVP (Retractable Tech)
The EV/EBITDA multiple determines the total enterprise value relative to operating profit, neutralizing the impact of debt loads and tax regimes to identify a fair market discount. By analyzing the EV/EBITDA ratio from a historical perspective, an investor can assess the extent to which the patent-protected technologies of Retractable Technologies (RVP) and stable US government contracts ensure capitalization resilience during macroeconomic shocks.
Competitors of Retractable Technologies (RVP)
EV/EBITDA Multiple ISRG (Intuitive Surgical Inc)|Total Company Value to Operating Income Before Depreciation Ratio Danaher Corporation Inc. (DHR)|BDX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|STE (steris.com) - Enterprise Value to Operating Income Before Depreciation|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BAX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio MASI|STVN (Stevanato Group Corp) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Teleflex Incorporated (TFX)|MMSI (merit.com) - Business Value to Operating Income Before Depreciation|Envista - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple ICU Medical Inc ICUI|XRAY - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LeMaitre Corp (LMAT) - Enterprise Value to EBITDA Ratio|ATRC: EV/EBITDA Multiple|Company Value to EBITDA staar.com (STAA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ChromaDex Corp.|Enterprise Value to Operating Income Before Depreciation ZIMV (ZimVie Inc)|Enterprise Value to EBITDA Ratio ANGO (AngioDynamics Corp)|Enterprise Value to Operating Income Before Depreciation Ratio CERS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alpha Teknova, Inc. TKNO|Total Company Value to Operating Income Before Depreciation Ratio monogramorthopedics.com (MGRM)|STSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation INFU (InfuSystem Holdings)|UTMD: EV/EBITDA Multiple|Company Value to EBITDA KORU Medical (KRMD)|Enterprise Value to EBITDA Ratio NYXH|MBOT (microbotmedical.com) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pro-Dex (PDEX)|ZTEK (Zentek Ltd) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ELUT (Elutia Corp)|EV/EBITDA Multiple Milestone Scientific Corporation MLSS|NEXGEL, Inc. - EV/EBITDA Multiple|Harvard Bioscience Inc. (HBIO) - Enterprise Value to EBITDA Ratio|FEMY (Femasys) - Enterprise Value to EBITDA Ratio|MHUA: Enterprise Value to Operating Income Before Depreciation Ratio|POAI (Predictive Oncology Inc) - EV/EBITDA Multiple|EV/EBITDA Multiple Callan JMB Corp|EV/EBITDA Multiple ATRI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NURO (neurometrix.com)
